These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30862109)

  • 1.
    Gu X; Wang L; Boldrup L; Coates PJ; Fahraeus R; Sgaramella N; Wilms T; Nylander K
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer.
    Wang Q; Yu X; Yang N; Xu L; Zhou Y
    PeerJ; 2021; 9():e11698. PubMed ID: 34316393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
    Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
    Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.
    Liu GX; Tan YZ; He GC; Zhang QL; Liu P
    Medicine (Baltimore); 2021 Oct; 100(41):e27535. PubMed ID: 34731149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.
    Xiong Z; Ge Y; Xiao J; Wang Y; Li L; Ma S; Lan L; Liu B; Qin B; Luan Y; Yang C; Ye Z; Wang Z
    Exp Biol Med (Maywood); 2023 Jan; 248(1):1-13. PubMed ID: 36408742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer.
    Hua T; Tian YJ; Wang RM; Zhao CF; Kong YH; Tian RQ; Wang W; Ma LX
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33870423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma.
    Tsai JC; Saad OA; Magesh S; Xu J; Lee AC; Li WT; Chakladar J; Fuster MM; Chang EY; Wang-Rodriguez J; Ongkeko WM
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
    Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
    Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HeRA: an atlas of enhancer RNAs across human tissues.
    Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
    Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
    Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
    Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
    Ye M; Wang S; Qie JB; Sun PL
    Front Oncol; 2021; 11():765484. PubMed ID: 34671565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.
    Liu J; Yin J; Wang Y; Cai L; Geng R; Du M; Zhong Z; Ni S; Huang X; Yu H; Bai J
    Biol Proced Online; 2022 Jul; 24(1):9. PubMed ID: 35836132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.
    Guo XY; Zhong S; Wang ZN; Xie T; Duan H; Zhang JY; Zhang GH; Liang L; Cui R; Hu HR; Lu J; Wu Y; Dong JJ; He ZQ; Mou YG
    Front Genet; 2021; 12():633812. PubMed ID: 33815468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
    Xiao J; Liu Y; Yi J; Liu X
    Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
    Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.
    Nohata N; Abba MC; Gutkind JS
    Oral Oncol; 2016 Aug; 59():58-66. PubMed ID: 27424183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia.
    Jiang Z; Long J; Deng K; Zheng Y; Chen M
    Front Mol Biosci; 2022; 9():877117. PubMed ID: 35586193
    [No Abstract]   [Full Text] [Related]  

  • 19. An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values.
    Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
    Am J Transl Res; 2021; 13(8):8611-8631. PubMed ID: 34539983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Origin of lncRNAs: Missing Link Found.
    Espinosa JM
    Trends Genet; 2017 Oct; 33(10):660-662. PubMed ID: 28778681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.